These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33138638)

  • 21. Diagnosis and Management of Idiopathic Pulmonary Fibrosis.
    Munchel JK; Shea BS
    R I Med J (2013); 2021 Sep; 104(7):26-29. PubMed ID: 34437662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are idiopathic pulmonary fibrosis patients more anxious and depressive than patient's with other interstitial lung disease?
    Yalnız E; Polat G; Demirci F; Deniz S; Karadeniz G; Aydınlı E; Vayisoglu G; Ayrancı A
    Sarcoidosis Vasc Diffuse Lung Dis; 2019; 36(4):294-301. PubMed ID: 32476965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exercise training-based pulmonary rehabilitation program is clinically beneficial for idiopathic pulmonary fibrosis.
    Vainshelboim B; Oliveira J; Yehoshua L; Weiss I; Fox BD; Fruchter O; Kramer MR
    Respiration; 2014; 88(5):378-88. PubMed ID: 25341682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nintedanib: A Review in Fibrotic Interstitial Lung Diseases.
    Lamb YN
    Drugs; 2021 Apr; 81(5):575-586. PubMed ID: 33765296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of a respiratory symptom diary for clinical studies of idiopathic pulmonary fibrosis.
    Bacci ED; O'Quinn S; Leidy NK; Murray L; Vernon M
    Respir Med; 2018 Jan; 134():130-138. PubMed ID: 29413500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Idiopathic Interstitial Pneumonia Associated With Autoantibodies: A Large Case Series Followed Over 1 Year.
    Collins BF; Spiekerman CF; Shaw MA; Ho LA; Hayes J; Spada CA; Stamato CM; Raghu G
    Chest; 2017 Jul; 152(1):103-112. PubMed ID: 28300570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disparate Interferon Signaling and Shared Aberrant Basaloid Cells in Single-Cell Profiling of Idiopathic Pulmonary Fibrosis and Systemic Sclerosis-Associated Interstitial Lung Disease.
    Valenzi E; Tabib T; Papazoglou A; Sembrat J; Trejo Bittar HE; Rojas M; Lafyatis R
    Front Immunol; 2021; 12():595811. PubMed ID: 33859634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of Palliative Care in End-of-Life of Fibrotic Interstitial Lung Disease Patients.
    Chai GT; Neo HY; Abisheganaden J; Hum AYM
    Am J Hosp Palliat Care; 2022 Dec; 39(12):1443-1451. PubMed ID: 35389277
    [No Abstract]   [Full Text] [Related]  

  • 29. Baseline characteristics and comorbidities in the CAnadian REgistry for Pulmonary Fibrosis.
    Fisher JH; Kolb M; Algamdi M; Morisset J; Johannson KA; Shapera S; Wilcox P; To T; Sadatsafavi M; Manganas H; Khalil N; Hambly N; Halayko AJ; Gershon AS; Fell CD; Cox G; Ryerson CJ
    BMC Pulm Med; 2019 Nov; 19(1):223. PubMed ID: 31771541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Healthcare Resources Utilization and Costs of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease Based on Insurance Claims in the USA.
    Olson AL; Maher TM; Acciai V; Mounir B; Quaresma M; Zouad-Lejour L; Wells CD; De Loureiro L
    Adv Ther; 2020 Jul; 37(7):3292-3298. PubMed ID: 32451950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Co-trimoxazole (Trimethoprim-Sulfamethoxazole) vs Placebo on Death, Lung Transplant, or Hospital Admission in Patients With Moderate and Severe Idiopathic Pulmonary Fibrosis: The EME-TIPAC Randomized Clinical Trial.
    Wilson AM; Clark AB; Cahn T; Chilvers ER; Fraser W; Hammond M; Livermore DM; Maher TM; Parfrey H; Swart AM; Stirling S; Thickett DR; Whyte M;
    JAMA; 2020 Dec; 324(22):2282-2291. PubMed ID: 33289822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The UCSD shortness of breath questionnaire has longitudinal construct validity in idiopathic pulmonary fibrosis.
    Swigris JJ; Han M; Vij R; Noth I; Eisenstein EL; Anstrom KJ; Brown KK; Fairclough D
    Respir Med; 2012 Oct; 106(10):1447-55. PubMed ID: 22801586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical course and management of idiopathic pulmonary fibrosis.
    Quinn C; Wisse A; Manns ST
    Multidiscip Respir Med; 2019; 14():35. PubMed ID: 31827795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clusters of comorbidities in idiopathic pulmonary fibrosis.
    Prior TS; Hoyer N; Hilberg O; Shaker SB; Davidsen JR; Rasmussen F; Bendstrup E
    Respir Med; 2021; 185():106490. PubMed ID: 34130097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sleep and respiratory sleep disorders in idiopathic pulmonary fibrosis.
    Milioli G; Bosi M; Poletti V; Tomassetti S; Grassi A; Riccardi S; Terzano MG; Parrino L
    Sleep Med Rev; 2016 Apr; 26():57-63. PubMed ID: 26168886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of hydromorphone on ventilation in palliative care patients with dyspnea.
    Clemens KE; Klaschik E
    Support Care Cancer; 2008 Jan; 16(1):93-9. PubMed ID: 17929063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sildenafil therapy and exercise tolerance in idiopathic pulmonary fibrosis.
    Jackson RM; Glassberg MK; Ramos CF; Bejarano PA; Butrous G; Gómez-Marín O
    Lung; 2010 Apr; 188(2):115-23. PubMed ID: 20012639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanical ventilation for acute respiratory failure due to idiopathic pulmonary fibrosis versus connective tissue disease-associated interstitial lung disease: Effectiveness and risk factors for death.
    Luo Z; Yang L; Liu S; Hu Y; Cao Z; Zhu J; Wang J; Ma Y
    Clin Respir J; 2020 Oct; 14(10):918-932. PubMed ID: 32460444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The long-term outcome of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies.
    Tanizawa K; Handa T; Nakashima R; Kubo T; Hosono Y; Watanabe K; Aihara K; Ikezoe K; Sokai A; Nakatsuka Y; Taguchi Y; Hatta K; Noma S; Kobashi Y; Yoshizawa A; Oga T; Hirai T; Chin K; Nagai S; Izumi T; Mimori T; Mishima M
    Respir Med; 2017 Jun; 127():57-64. PubMed ID: 28461123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A cohort study of Danish patients with interstitial lung diseases: burden, severity, treatment and survival.
    Hyldgaard C
    Dan Med J; 2015 Apr; 62(4):B5069. PubMed ID: 25872544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.